Moreover, we show that autophagy resulting from CEMM disruption is involved in doxorubicin (Doxo) resistance in breast cancer cells with low CAV1 expression, while suppression of autophagy by hydroxychloroquine (HCQ) overcomes the drug resistance. This evidence concerns the gene CAV1 and breast cancer.